« Back to Record
Citation APA

Delwaide, J., Bourgeois, N., Gérard, C., De Maeght, S., Mokaddem, F., Wain, E., Bastens, B., Fevery, J., Géhénot, M., Le Moine, O., Martinet, J.-P., Robaeys, G., Servais, B., Van Gossum, M., Van Vlierberghe, H., & Belgian Association for the Study of the Liver (BASL), (2004). Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Alimentary pharmacology & therapeutics, 20(1), 15-22. doi:10.1111/j.1365-2036.2004.02023.x


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/111090

Delwaide, J., Bourgeois, N., Gérard, C., De Maeght, S., Mokaddem, F., Wain, E., Bastens, B., Fevery, J., Géhénot, M., Le Moine, O., Martinet, J.-P., Robaeys, G., Servais, B., Van Gossum, M., Van Vlierberghe, H., & Belgian Association for the Study of the Liver (BASL), (2004). Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response. Alimentary pharmacology & therapeutics, 20(1), 15-22. doi:10.1111/j.1365-2036.2004.02023.x